These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1891780)

  • 1. Dose-dependent reversal of acute murine colchicine poisoning by goat colchicine-specific Fab fragments.
    Sabouraud A; Urtizberea M; Grandgeorge M; Gattel P; Makula ME; Scherrmann JM
    Toxicology; 1991; 68(2):121-32. PubMed ID: 1891780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of murine colchicine toxicity by colchicine-specific Fab fragments.
    Urtizberea M; Sabouraud A; Cano N; Grandgeorge M; Rouzioux JM; Scherrmann JM
    Toxicol Lett; 1991 Oct; 58(2):193-8. PubMed ID: 1949077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colchicine-specific Fab fragments alter colchicine disposition in rabbits.
    Sabouraud AE; Urtizberea M; Cano NJ; Grandgeorge M; Rouzioux JM; Scherrmann JM
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1214-9. PubMed ID: 1545388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-colchicine Fab fragments prevent lethal colchicine toxicity in a porcine model: a pharmacokinetic and clinical study.
    Eddleston M; Fabresse N; Thompson A; Al Abdulla I; Gregson R; King T; Astier A; Baud FJ; Clutton RE; Alvarez JC
    Clin Toxicol (Phila); 2018 Aug; 56(8):773-781. PubMed ID: 29334816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of goat colchicine specific antibodies on murine colchicine disposition.
    Terrien N; Urtizberea M; Scherrmann JM
    Toxicology; 1989 Nov; 59(1):11-22. PubMed ID: 2815097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotoxicotherapy: successes, disappointments and hopes.
    Bismuth C; Borron SW; Baud FJ; Taboulet P; Scherrmann JM
    Hum Exp Toxicol; 1997 Oct; 16(10):602-8. PubMed ID: 9363479
    [No Abstract]   [Full Text] [Related]  

  • 7. Fab antibody fragments: some applications in clinical toxicology.
    Flanagan RJ; Jones AL
    Drug Saf; 2004; 27(14):1115-33. PubMed ID: 15554746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of advanced digitoxin toxicity and modification of pharmacokinetics by specific antibodies and Fab fragments.
    Ochs HR; Smith TW
    J Clin Invest; 1977 Dec; 60(6):1303-13. PubMed ID: 914999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of rabbit anti-mouse renin specific Fab fragments.
    Lykkegård S
    Acta Pathol Microbiol Scand C; 1979 Apr; 87C(2):91-7. PubMed ID: 443051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical control procedures of immunoreactivity for IgG and Fab fragments specific to haptens.
    Cano NJ; Sabouraud AE; Urtizberea M; Carcagne J; Grandgeorge M; Scherrmann JM
    Pharm Res; 1992 May; 9(5):643-7. PubMed ID: 1608896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of advanced colchicine toxicity in mice with goat colchicine-specific antibodies.
    Terrien N; Urtizberea M; Scherrmann JM
    Toxicol Appl Pharmacol; 1990 Jul; 104(3):504-10. PubMed ID: 2385840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brief report: treatment of severe colchicine overdose with colchicine-specific Fab fragments.
    Baud FJ; Sabouraud A; Vicaut E; Taboulet P; Lang J; Bismuth C; Rouzioux JM; Scherrmann JM
    N Engl J Med; 1995 Mar; 332(10):642-5. PubMed ID: 7845428
    [No Abstract]   [Full Text] [Related]  

  • 13. Fab-bound colchicine appears to adopt Fab fragment disposition in rats.
    Sabouraud AE; Urtizberea M; Benmoussa K; Cano NJ; Scherrmann JM
    J Pharm Pharmacol; 1992 Dec; 44(12):1015-9. PubMed ID: 1361548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digoxin-specific antibody fragments in the treatment of digoxin toxicity.
    Chan BS; Buckley NA
    Clin Toxicol (Phila); 2014; 52(8):824-36. PubMed ID: 25089630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and organ distribution of cationized colchicine-specific IgG and Fab fragments in rat.
    Hong G; Bazin-Redureau MI; Scherrmann JM
    J Pharm Sci; 1999 Jan; 88(1):147-53. PubMed ID: 9874717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of lethal digoxin toxicity in guinea pigs using monoclonal antibodies and Fab fragments.
    Lechat P; Mudgett-Hunter M; Margolies MN; Haber E; Smith TW
    J Pharmacol Exp Ther; 1984 Apr; 229(1):210-3. PubMed ID: 6707937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of digoxin specific Fab fragments (Digibind) in the treatment of toad venom poisoning.
    Brubacher JR; Lachmanen D; Ravikumar PR; Hoffman RS
    Toxicon; 1999 Jun; 37(6):931-42. PubMed ID: 10340832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunopharmacological activity of monoclonal antidigitoxin.
    Urtizberea M; Latour M; Edelman L; Carcagne J; Armand J; Scherrmann JM
    Dev Biol Stand; 1990; 71():147-57. PubMed ID: 2401380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simplified preparation of rabbit Fab fragments.
    Coulter A; Harris R
    J Immunol Methods; 1983 Apr; 59(2):199-203. PubMed ID: 6341469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.